TL;DR
Get everyday helpers delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study published in JAMA Cardiology found that people who later experienced cardiovascular disease had worse frailty, intrinsic capacity and physical health measures than matched controls, with differences widening in the five years before an event. The observational findings show a long-term association; they do not establish that functional decline causes cardiovascular disease or that screening for it prevents events.
A study of 12,015 older adults found that people who later experienced a cardiovascular event had worse measures of frailty, physical capacity and health-related quality of life years beforehand, with gaps widening as the event approached. Published online Sept. 23 in JAMA Cardiology, the analysis points to a possible long period for closer clinical evaluation, but does not show that functional decline causes cardiovascular disease or that intervening on these measures prevents an event.
Aung Zaw Zaw Phyo of Monash University in Melbourne and colleagues examined participants in the Aspirin in Reducing Events in the Elderly cohort. The nested case-control analysis included 2,403 people who experienced a cardiovascular event and 9,612 matched controls. Researchers compared measures of functional aging over time before the cases’ events.
Before an event, the case group had consistently higher frailty, lower intrinsic capacity and poorer physical health-related quality of life than the controls, the researchers reported. These are distinct measures of health and function; the report does not say that any one measure alone could predict which individual would experience a cardiovascular event.
Differences widened markedly in the five years before an event. Over time, the cases had faster increases in frailty and steeper declines in intrinsic capacity and physical health-related quality of life. The reported statistical estimates included increases in the Frailty Index (β = 0.78) and Fried phenotype frailty (β = 0.05), alongside declines in intrinsic capacity (β = −0.34) and physical health-related quality of life (β = −0.55). These estimates describe the study’s model results and should not be read as percentage changes.
A Longer Window for Clinical Review
The findings matter because they suggest that changes in overall function may be present well before cardiovascular disease becomes clinically apparent. If clinicians observe declining physical capacity or increasing frailty, those patterns could help prompt a broader review of a patient’s health and cardiovascular risks. The study does not establish a specific screening approach, however, or show that tracking these measures would reduce heart attacks, strokes or deaths.
The authors describe the results as suggesting a prolonged window for closer clinical evaluation and early intervention. That is an interpretation of the observed trajectories, not evidence that a particular intervention works. For readers, the central point is an association at the group level: people who later had events showed poorer functional profiles over time, but the analysis cannot determine what will happen to any one person.
The results also highlight that cardiovascular events may occur amid broader changes in health and functioning, rather than appearing against an otherwise unchanged baseline. Further research would be needed to determine whether functional measures add useful predictive information beyond established risk factors and whether acting on that information improves outcomes.
frailty assessment tools for seniors
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Researchers Compared Participants
The research, titled Multidimensional Aging Trajectories Preceding Cardiovascular Events, was published in JAMA Cardiology and used data from the Aspirin in Reducing Events in the Elderly cohort. Researchers compared participants who experienced cardiovascular events with matched controls, then examined differences in functional measures during the years leading up to the events.
The study considered a composite of cardiovascular outcomes and also examined patterns across its components. The reported divergence appeared at least 10 years beforehand for heart failure and fatal coronary heart disease. For myocardial infarction and stroke, the patterns were similar overall, but the divergence did not appear as early, the report said. The supplied report does not provide further detail on the timing for those two outcomes.
The distinction between association and cause is central to interpreting this work. Because the analysis followed measures before events, it can describe when group differences emerged; it cannot by itself show that functional decline led to the disease, identify the biological pathway involved or rule out other factors contributing to both declining function and cardiovascular risk.
“Declines in functional aging markers were prominent before clinically apparent CVD.”
— Aung Zaw Zaw Phyo and colleagues, writing in JAMA Cardiology
physical health monitoring devices for elderly
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What the Study Cannot Establish
The analysis shows that poorer functional measures were associated with later cardiovascular events in this cohort; it does not establish that declining function causes cardiovascular disease. Nor does it demonstrate that measuring frailty or intrinsic capacity can predict an individual’s event, or that changing those measures lowers risk.
The report does not specify the exact event counts for each cardiovascular outcome, the full participant characteristics, or the detailed measurement schedules and statistical methods. It also does not provide numerical estimates for every outcome-specific trajectory. The reported β values should be interpreted within the study’s own models rather than as simple changes in everyday units.
The cohort and its findings may not represent all age groups or populations. The study’s next practical implications remain uncertain: further work is needed to test whether functional measures improve existing risk assessment and what clinical response, if any, would be useful.
intrinsic capacity evaluation kits
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing Whether Earlier Review Helps
The report does not announce a follow-up trial, clinical guideline change or scheduled next milestone. The immediate next step for research is to determine whether the observed functional trajectories can be replicated in other populations and whether they improve prediction beyond conventional cardiovascular risk assessments.
Studies would also need to test whether a clinical strategy based on functional decline leads to better outcomes, rather than simply identifying people who are already on a path toward an event. Until that evidence is available, the authors’ suggestion of closer evaluation should be understood as a potential opportunity for further study, not a new screening recommendation. People making decisions about cardiovascular risk or changes in health should consult a qualified health professional.
senior fall detection and mobility aids
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the study find?
People who later experienced cardiovascular events had worse frailty, intrinsic capacity and physical health-related quality of life than matched controls, with differences widening in the years before the event.
How far ahead of an event were differences seen?
The study found worse functional profiles up to a decade before events overall. Divergence appeared at least 10 years ahead for heart failure and fatal coronary heart disease; it appeared later for myocardial infarction and stroke.
Does functional decline cause cardiovascular disease?
The study does not establish cause. It reports an association between declining functional measures and later events in the participants studied.
Does this mean frailty screening prevents heart attacks or strokes?
No. The researchers did not test whether screening or intervention based on these measures prevents cardiovascular events. Further studies are needed to assess their value in clinical risk evaluation.
Who took part in the analysis?
The analysis included 12,015 participants from the Aspirin in Reducing Events in the Elderly cohort: 2,403 who experienced a cardiovascular event and 9,612 matched controls.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
